Trial · NCT02420821
Adverse events706
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 706
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | ANAEMIA | Blood and lymphatic system disorders | Sunitinib | 104 | 446 | 177 |
| other | ANAEMIA | Blood and lymphatic system disorders | Atezolizumab + Bevacizumab | 51 | 451 | 81 |
| other | LEUKOPENIA | Blood and lymphatic system disorders | Sunitinib | 31 | 446 | 65 |
| other | LEUKOPENIA | Blood and lymphatic system disorders | Atezolizumab + Bevacizumab | 5 | 451 | 13 |
| other | NEUTROPENIA | Blood and lymphatic system disorders | Sunitinib | 62 | 446 | 157 |
| other | NEUTROPENIA | Blood and lymphatic system disorders | Atezolizumab + Bevacizumab | 5 | 451 | 7 |
| other | THROMBOCYTOPENIA | Blood and lymphatic system disorders | Sunitinib | 80 | 446 | 172 |
| other | THROMBOCYTOPENIA | Blood and lymphatic system disorders | Atezolizumab + Bevacizumab | 15 | 451 | 36 |
| other | HYPERTHYROIDISM | Endocrine disorders | Sunitinib | 14 | 446 | 16 |
| other | HYPERTHYROIDISM | Endocrine disorders | Atezolizumab + Bevacizumab | 31 | 451 | 32 |
| other | HYPOTHYROIDISM | Endocrine disorders | Sunitinib | 130 | 446 | 149 |
| other | HYPOTHYROIDISM | Endocrine disorders | Atezolizumab + Bevacizumab | 109 | 451 | 123 |
| other | ABDOMINAL PAIN | Gastrointestinal disorders | Sunitinib | 42 | 446 | 69 |
| other | ABDOMINAL PAIN | Gastrointestinal disorders | Atezolizumab + Bevacizumab | 42 | 451 | 51 |
| other | ABDOMINAL PAIN UPPER | Gastrointestinal disorders | Sunitinib | 40 | 446 | 67 |
| other | ABDOMINAL PAIN UPPER | Gastrointestinal disorders | Atezolizumab + Bevacizumab | 22 | 451 | 24 |
| other | CONSTIPATION | Gastrointestinal disorders | Sunitinib | 68 | 446 | 87 |
| other | CONSTIPATION | Gastrointestinal disorders | Atezolizumab + Bevacizumab | 86 | 451 | 106 |
| other | DIARRHOEA | Gastrointestinal disorders | Sunitinib | 239 | 446 | 632 |
| other | DIARRHOEA | Gastrointestinal disorders | Atezolizumab + Bevacizumab | 150 | 451 | 273 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02420821/events